June 7, 2016 / 3:18 PM / 2 years ago

BUZZ-U.S. biotechs trip while stocks march higher

** S&P Health Care index only sector in the red, down 0.5 pct, as sour biotech news caps broader market gains

** Nasdaq Biotech Index off 2.4 pct, paring earlier losses. Index fell more than 3 pct, its biggest drop in nearly a month

** Biogen (-13 pct) and Alexion Pharmaceuticals (-11 pct) biggest drags on S&P 500 after reporting their respective drugs failed in trials

** Though both stocks off by similar percentage, trader notes more bearish sentiment around ALXN as investors were factoring in high probability its Soliris drug would succeed

** And Valeant continues to cast a pall on sector after troubled Canadian drugmaker slashes its forecast again; NYSE-listed shares drop as much as a fifth before recovering a bit

** Meanwhile, SPX rises 0.3 pct, hits an 11-month high; SPX up 3.5 pct in 2016 while health care stocks are flat

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below